NVO
Novo Nordisk A/S
$48.38
0.31 (0.63%) Today
— up— down
Market Cap
$1.40T-29.3%
Revenue (TTM)
$249.69B+8.1%
Net Income (TTM)
$92.92B+16.7%
EPS (TTM)
27.41+16.7%
Shares Out
3.39B
3.39BP/E Ratio
11.47
11.47Forward P/E
14.36
14.36Dividend
$11.66 (3.68%)
$11.66 (3.68%)Ex-Dividend Date
Mar 30, 2026
Mar 30, 2026Open
$47.72
$47.72Previous Close
$48.07
$48.07Day Range
$47.61 – $48.45
$47.61 – $48.4552-Week Range
$35.12 – $71.80
$35.12 – $71.80Beta
1.89
1.89Volume
5.97M
5.97MAvg Volume
6.73M
6.73MAnalyst Rating
Hold
HoldExchange
OMX NORDIC EXCHANGE COPENHAGEN A/S
OMX NORDIC EXCHANGE COPENHAGEN A/SAbout NVO
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority (77.1%) of its voting shares.
Related
News
Novo Nordisk: 3 Key Reasons The 'Buy The Dip' Thesis Is Flawed
SeekingAlpha · 3d ago
Novo Nordisk: A Strong Yield And Continued Growth
SeekingAlpha · 5d ago
Novo Nordisk: The Selloff Looks Like A Gift, And I'm Buying
SeekingAlpha · 6d ago
Novo Nordisk Stock Is Surging Monday: What's Driving The Action?
Benzinga · 1w ago